AstraZeneca

Legal Clash: AstraZeneca Fights to Overturn Louisiana’s Controversial 340B Law in Appeals Court

by

New Orleans, Louisiana — An attorney representing AstraZeneca argued before an appeals court this week for the invalidation of a state law concerning the 340B Drug Pricing Program. This legal dispute highlights a growing concern among pharmaceutical companies regarding the impact of similar legislation across the United States. The attorney contended that the Louisiana law significantly alters how drug pricing is managed, contending that it imposes restrictions that could disrupt the pharmaceutical industry’s operations. The 340B program is designed to enable healthcare providers serving high numbers of low-income patients to purchase drugs at reduced prices. … Read more

Court Sides with AstraZeneca, Nullifies Pfizer’s $107.5 Million Patent Victory

by

Washington, D.C. — A federal appeals court has overturned a previous jury verdict that awarded Pfizer $107.5 million, ruling in favor of AstraZeneca in a high-stakes patent infringement lawsuit. The decision marks a significant win for the British-Swedish pharmaceutical giant in the competitive pharmaceutical landscape. The case centered on Pfizer’s claims that AstraZeneca had infringed upon its patents related to a blockbuster medication. Pfizer, headquartered in New York City, had successfully convinced a jury of the infringement, securing a hefty sum as compensation for damages. However, the appellate court found substantial issues in the initial … Read more